Extended Input Deadline for USP´s new Chapter on Quality Considerations for Cannabis

Recommendation
12/13 November 2025
How to implement EU-GMP Chapter 8
Following the previously announced elaboration of a new USP chapter <1568> Quality Considerations for Cannabis and Cannabis-derived Products for Clinical Research the input deadline has been extended to 31 July 2022.
USP is requesting early input from stakeholders on the proposed new General Chapter <1568> which is then expected to be published for comment in Pharmacopeial Forum.
More Information is available at the USP Compendial Notices Website.
Related GMP News
07.10.2025Impurities and Contaminants in Food Supplements
07.10.2025Determination of Thujone
07.10.2025Microscopic Examination of Herbal Drugs
10.09.2025Final Revised GACP Guideline Published
28.08.2025Draft Public Statement on Cannabis Flos
28.08.2025Revised Ph. Eur. Cannabis Monograph


